{"filing":{"accession_number":"0001193125-26-295000","cik":"0001859795","ticker":"NVNXF","company_name":"NOVONIX Ltd","form":"6-K","filing_date":"2026-07-02","report_date":null,"primary_document":"nvx-6k-july-2026-03-07-a.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1859795/000119312526295000/nvx-6k-july-2026-03-07-a.htm"},"events":[{"id":16023,"run_id":14294,"accession_number":"0001193125-26-295000","anchor_item_number":"EX-99.1","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"This is an ASX Appendix 2A application for quotation of 34,824 ordinary shares issued on vesting of 54,480 performance rights under an employee incentive scheme on 2–3 July 2026. While the immediate issuance is modest in absolute terms, it represents a dilutive equity event (conversion of unquoted performance rights into quoted ordinary shares) that increases the share count and would be material to a reasonable investor assessing capital structure and dilution. The document confirms the securities rank equally with existing ordinary shares and notes substantial unquoted convertible securities (45.2M convertible notes, 35M convertible debentures) that pose future dilution risk.","company_name":"NOVONIX Ltd","ticker":"NVNXF","filing_date":"2026-07-02","form":"6-K","submitted_at":null,"items":[{"id":13972,"accession_number":"0001193125-26-295000","item_number":"EX-99.1","item_title":"nvx-ex99_1.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"This is an ASX Appendix 2A application for quotation of 34,824 ordinary shares issued on vesting of 54,480 performance rights under an employee incentive scheme on 2–3 July 2026. While the immediate issuance is modest in absolute terms, it represents a dilutive equity event (conversion of unquoted performance rights into quoted ordinary shares) that increases the share count and would be material to a reasonable investor assessing capital structure and dilution. The document confirms the securities rank equally with existing ordinary shares and notes substantial unquoted convertible securities (45.2M convertible notes, 35M convertible debentures) that pose future dilution risk.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-02T21:31:37.681350+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":13972,"accession_number":"0001193125-26-295000","item_number":"EX-99.1","item_title":"nvx-ex99_1.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"This is an ASX Appendix 2A application for quotation of 34,824 ordinary shares issued on vesting of 54,480 performance rights under an employee incentive scheme on 2–3 July 2026. While the immediate issuance is modest in absolute terms, it represents a dilutive equity event (conversion of unquoted performance rights into quoted ordinary shares) that increases the share count and would be material to a reasonable investor assessing capital structure and dilution. The document confirms the securities rank equally with existing ordinary shares and notes substantial unquoted convertible securities (45.2M convertible notes, 35M convertible debentures) that pose future dilution risk.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-02T21:31:37.681350+00:00","company_name":"NOVONIX Ltd","ticker":"NVNXF","filing_date":"2026-07-02"}]}